Ross operation with decellularized xenogenic heart valve for RVOT reconstruction

2007 ◽  
Vol 55 (S 1) ◽  
Author(s):  
PM Dohmen ◽  
D Gabbieri ◽  
S Dushe ◽  
A Lembcke ◽  
S Holinski ◽  
...  
Keyword(s):  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Shaohua Wu ◽  
Vikas Kumar ◽  
Peng Xiao ◽  
Mitchell Kuss ◽  
Jung Yul Lim ◽  
...  

AbstractHeart valve disease is a common manifestation of cardiovascular disease and is a significant cause of cardiovascular morbidity and mortality worldwide. The pulmonary valve (PV) is of primary concern because of its involvement in common congenital heart defects, and the PV is usually the site for prosthetic replacement following a Ross operation. Although effects of age on valve matrix components and mechanical properties for aortic and mitral valves have been studied, very little is known about the age-related alterations that occur in the PV. In this study, we isolated PV leaflets from porcine hearts in different age groups (~ 4–6 months, denoted as young versus ~ 2 years, denoted as adult) and studied the effects of age on PV leaflet thickness, extracellular matrix components, and mechanical properties. We also conducted proteomics and RNA sequencing to investigate the global changes of PV leaflets and passage zero PV interstitial cells in their protein and gene levels. We found that the size, thickness, elastic modulus, and ultimate stress in both the radial and circumferential directions and the collagen of PV leaflets increased from young to adult age, while the ultimate strain and amount of glycosaminoglycans decreased when age increased. Young and adult PV had both similar and distinct protein and gene expression patterns that are related to their inherent physiological properties. These findings are important for us to better understand the physiological microenvironments of PV leaflet and valve cells for correctively engineering age-specific heart valve tissues.


2002 ◽  
Vol 74 (5) ◽  
pp. 1438-1442 ◽  
Author(s):  
Pascal M Dohmen ◽  
Alexander Lembcke ◽  
Holger Hotz ◽  
Dietmar Kivelitz ◽  
Wolfgang F Konertz

1991 ◽  
Vol 9 (2) ◽  
pp. 329-338 ◽  
Author(s):  
Jorge A. Wernly ◽  
Michael H. Crawford

2009 ◽  
Vol 56 (S 01) ◽  
Author(s):  
P Akhyari ◽  
H Ziegler ◽  
P Mambou ◽  
M Barth ◽  
S Hoffmann ◽  
...  
Keyword(s):  

2009 ◽  
Vol 56 (S 01) ◽  
Author(s):  
A Böning ◽  
S Haberer ◽  
UP Rosendahl ◽  
I Florath ◽  
JC Ennker

2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
H Schröfel ◽  
G Schymik ◽  
A Würth ◽  
V Elsner ◽  
BD Gonska ◽  
...  

2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
S Subramanian ◽  
G Pettersson ◽  
L Svensson
Keyword(s):  

1997 ◽  
Vol 77 (05) ◽  
pp. 0839-0844 ◽  
Author(s):  
Vittorio Pengo ◽  
Fabio Barbero ◽  
Alberto Banzato ◽  
Elisabetta Garelli ◽  
Franco Noventa ◽  
...  

SummaryBackground. The long-term administration of oral anticoagulants to patients with mechanical heart valve prostheses is generally accepted. However, the appropriate intensity of oral anticoagulant treatment in these patients is still controversial.Methods and Results. From March 1991 to March 1994, patients referred to the Padova Thrombosis Center who had undergone mechanical heart valve substitution at least 6 months earlier were randomly assigned to receive oral anticoagulants at moderate intensity (target INR = 3) or moderate-high intensity (target INR = 4). Principal end points were major bleeding, thromboembolism and vascular death. Minor bleeding was a secondary end-point.A total of 104 patients were assigned to the target 3 group and 101 to the target 4 group; they were followed for from 1.5 years to up 4.5 years (mean, 3 years). Principal end-points occurred in 13 patients in the target 3 group (4 per 100 patient-years) and in 20 patients in the target 4 group (6.9 per 100 patient-years). Major hemorrhagic events occurred in 15 patients, 4 in the target 3 group (1.2 per 100 patient-years) and 11 in the target 4 group (3.8 per 100 patient-years) (p = 0.019). The 12 recorded episodes of thromboembolism, 4 of which consisted of a visual deficit, were all transient ischemic attacks, 6 in the target 3 group (1.8 per 100 patient-years) and 6 in the target 4 group (2.1 per 100 patient- years). There were 3 vascular deaths in each group (0.9 and 1 per 100 patient-years for target 3 and target 4 groups, respectively). Minor bleeding episodes occurred 85 times (26 per 100 patient-years) in the target 3 group and 123 times (43 per 100 patient-years) in the target 4 group (p = 0.001).Conclusions. Mechanical heart valve patients on anticoagulant treatment who had been operated on at least 6 months earlier experienced fewer bleeding complications when maintained on a moderate intensity regimen (target INR = 3) than those on a moderate-high intensity regimen (target INR = 4). The number of thromboembolic events and vascular deaths did not differ between the two groups.


Sign in / Sign up

Export Citation Format

Share Document